What should be the standard of care for cancer surveillance, diagnosis of dysplasia, and the decision for colectomy in chronic inflammatory bowel disease?

American Journal of Gastroenterology

Volumn 97, Issue 5, 2002, Pages 1249-1255

  Hookman, Perry ^a   Barkin, Jamie S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER STAGING; COLON CANCER; COLON RESECTION; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DYSPLASIA; EARLY DIAGNOSIS; ENTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NOTE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK ASSESSMENT; ULCERATIVE COLITIS;

EID: 0036245313     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04034-0     Document Type: Note

References (75)

1. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific)
2. Ulcerative colitis and carcinoma coli
3. Course and prognosis of ulcerative colitis. IV; Carcinoma of colon
4. The cancer risk in ulcerative colitis
5. Ulcerative colitis and colorectal cancer: A population-based study
6. Cancer risk and life expectancy of children with ulcerative colitis
7. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers
8. Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice
9. Colorectal and extracolonic malignancy in ulcerative colitis
10. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
11. The rue risk of colorectal cancer in ulcerative colitis: A meta-analysis
12. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis
13. Folate, methionine and alcohol intake and risk of colorectal adenoma
14. Folic acid is associated with a favorable Dukes' stage in colorectal cancer in ulcerative colitis
15. Effect of folate deficiency on formation of azoxymethane-induced aberrant crypt foci in the rat colon
16. Local complications of ulcerative colitis: Stricture, pseudopolyposis and carcinoma of colon and rectum
17. The course and prognosis of ulcerative colitis
18. Cancer in universal and left-sided ulcerative colitis: Factors determining risk
19. Cancer surveillance in ulcerative colitis. Experience over 15 years
20. Cancer morbidity in ulcerative colitis
21. Colorectal cancer risk and mortality in patients with ulcerative colitis
22. Cancer surveillance in ulcerative colitis - A time for reappraisal
23. Hazard rates for dysplasia and cancer in ulcerative colitis
24. Failure of colonoscopic surveillance in ulcerative colitis
25. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
26. Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia
27. Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance
28. Cancer surveillance in ulcerative colitis
29. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention
30. Cancer in colitis: Assessment of the individual risk by clinical and histological criteria
31. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis
32. Performing a cost-effectiveness analysis: Surveillance of patients with ulcerative colitis
33. Cancer risk in ulcerative colitis: Surveillance or surgery
34. Colon cancer, dysplasia and surveillance in patients with ulcerative colitis: A critical review
35. Cancer surveillance in ulcerative colitis: A time for reappraisal
36. Cancer surveillance in ulcerative colitis: More of the same or progress?
37. Screening strategies in gastrointestinal cancer
38. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
39. Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance
40. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis
41. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis
42. Sigmoidoscopy and biopsy in surveillance for cancer in ulcerative colitis
43. The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis
44. Value of sigmoidoscopy and biopsy in detection of carcinoma and premalignant change in ulcerative colitis
45. Surveillance in the routine management of ulcerative colitis. The predictive value of low-grade dysplasia
46. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention
47. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
48. Cancer surveillance of patients with long-standing ulcerative colitis: A clinical endoscopic and histological study
49. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program
50. Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance program
51. Failure of colonoscopic surveillance in ulcerative colitis
52. Cancer surveillance in ulcerative colitis
53. Surveillance for colonic carcinoma in ulcerative colitis
54. Colonoscopy surveillance for cancer in patients with chronic ulcerative colitis: Is it working?
55. Colon cancer, dysplasia and surveillance in patients with ulcerative colitis: A critical review
56. Cancer surveillance in ulcerative colitis - A time for reappraisal
57. Screening for colorectal cancer in ulcerative colitis: Dubious benefits and high costs
58. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis
59. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population-based case control study
60. Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study
61. Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance program
62. Colonoscopic surveillance in longstanding total ulcerative colitis - A 15 year follow-up study
63. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
64. How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?
65. Physician's perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis
66. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis
67. Benign and malignant colorectal strictures in ulcerative colitis
68. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy
69. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: A clinical, pathological and molecular review
70. Adenoma-like polypoid dysplasia in chronic ulcerative colitis: A follow-up study of 23 cases
71. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
72. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
73. Dysplasia and deoxyribonucleic acid aneuploidy in assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations